Amendment allows for the development of IVD test kits compatible with Illumina technology TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its IVD Test Developmentand Component Supply Agreement with Illumina, Inc. (Illumina), previously amended in June 2017, to enable the expansion of potential fields for […]
MELBOURNE, Australia — MGI, a division of global genomics leader BGI Group, announced that Micromon Genomics is the first Australian commercial user of its high-throughput genetic sequencer MGISEQ-2000. Monash University’s Micromon Genomics, a next-generation sequencing facility located in the university’s Biomedical precinct at the Clayton campus in Melbourne, provides sequencing services to Australian researchers, including DNA, RNA, single cell and […]
This new enzyme-based system allows scientists to accurately and sensitively assess DNA methylation without bisulfite treatment, for epigenetics research. IPSWICH, MA — New England Biolabs (NEB®) today announced the launch of NEBNext® Enzymatic Methyl-seq (EM-seq™), an enzyme-based alternative to bisulfite sequencing for methylation analysis. Bisulfite treatment has long been the gold standard for methylome analysis, specifically […]
Simultaneously Closes Strategic Growth Investment from Ampersand Capital to Create a Leading Provider of Genomic and Cell and Tissue Analysis Products and Services ST. LOUIS — Canopy BiosciencesTM, LLC, a leading provider of gene editing and gene expression products and services, announced today that it has acquired Zellkraftwerk GmbH, a leader in multiplex cytometry. Leveraging […]
MGI Welcomes Collaborators for Diverse Genomes Project, using Single Tube Long Fragment Read (stLFR) Approach to Reduce Cost and Error Rates SEOUL – MGI, a subsidiary of BGI Group, is expanding applications for a new sequencing solution called single tube long fragment read (stLFR) technology, which achieves affordable sequencing, haplotyping, and de novo assembly using unique […]
Strategic collaboration between two organisations represents largest nanopore sequencing project to date, capitalising on recent developments bringing ultra-high yields with PromethION GrandOmics, a leading sequencing company in China, has announced a populational-scale project, dbSV100k, to understand the impact of structural variation on human disease. The project aims to sequence 20,000 human genomes in 2019, with […]
STONY BROOK, N.Y. – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions, announced today that it has received the first $1 million of a $5 million licensing fee as per the terms of its exclusive agreement entered into with TheraCann International Corporation (“TheraCann”) on March […]
TUSTIN, Calif. — Franek Technologies has configured an uninterruptible power supply unit to support the Applied Biosystems Prism® 7500 RealTime PCR Sequence Detector with Controller. Franek had numerous requests from various laboratories that have a need for a battery backup solution for their Applied Biosystems Prism® 7500 Real-Time Sequence Detector with Controller. Franek has developed a plug and play solution for every lab that […]
Pacific Biosciences Launches New Sequel II System, Featuring ~8 Times the DNA Sequencing Data Output
New system is ideally suited for comprehensive variant detection, large genome de novoassembly, human structural variant characterization, whole transcriptome analysis, and more MENLO PARK, Calif. — Pacific Biosciences of California Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced the commercial launch of the Sequel® II System. The system includes the new SMRT® Cell 8M, […]
US patent number 10,266,850 was previously involved in an interference proceeding DUBLIN, Ireland: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, announced today that the US Patent Office has issued US patent number 10,266,850 to Dr. Charpentier, together with The Regents of the […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
